Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity
Funding for Substance Use Prevention Treatment and Recovery Services block grant
Implementation of legislative provisions related to substance abuse treatment and prevention; IMD exclusion; Family First Prevention Services Act provisions; 42 CFR part 2 patient confidentiality reform; Family First Transition Act, workforce development
Duration: June 8, 2010
to
present
General Issues: Alcohol & Drug Abuse , Budget/Appropriations , Health Issues , Medicare/Medicaid
Spending: about $550,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2010: U.S. Senate, House of Representatives, Substance Abuse & Mental Health Services Administration (SAMHSA), Office of Natl Drug Control Policy (NDCP), Centers For Medicare and Medicaid Services (CMS), Centers For Medicare and Medicaid Services (CMS)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Robert Zucker
LD, Rep. Rothman; LA,Rep. Evans (IL); SA/LC,Sen. Lautenberg
LD, Rep. Rothman; LA,Rep. Evans (IL); Sen. Lautenberg
Michael Merola
Deputy CoS, Sen. Torricelli
Charla Penn McManus
LA, Rep. Pascrell; SA/LC/LA, Rep. Boyd
Charla Penn McManus
LA, Rep. Pascrell; SA/LC/LA, Rep. Boyd
Chelsey Hickman
CoS, Rep. Kay Granger; LA Sen. Larry Craig
Molly McDonnell
LC/LA/Senior Health Policy Advisor; Congressman Leonard Lance
Chelsey Penrod Hickman
CoS, Rep. Kay Granger; LA Sen. Larry Craig
Charla Penn
LA, Rep. Pascrell; SA/LC/LA, Rep. Boyd
Charla McManus
n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America , earning $10,000. The report was filed on April 22.
Original Filing: 301575418.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA) Office of Natl Drug Control Policy (NDCP)
Lobbying Issues
Funding for Substance Use Prevention Treatment and Recovery Services block grant
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Implementation of legislative provisions related to substance abuse treatment and prevention; IMD exclusion; Family First Prevention Services Act provisions; 42 CFR part 2 patient confidentiality reform; Family First Transition Act, workforce development
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
4th Quarter, 2023
In Q4, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America , earning $10,000. The report was filed on Jan. 22.
Original Filing: 301536779.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA) Office of Natl Drug Control Policy (NDCP)
Lobbying Issues
Funding for Substance Use Prevention Treatment and Recovery Services block grant
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Implementation of legislative provisions related to substance abuse treatment and prevention; IMD exclusion; Family First Prevention Services Act provisions; 42 CFR part 2 patient confidentiality reform; Family First Transition Act, workforce development
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
3rd Quarter, 2023
In Q3, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America , earning $10,000. The report was filed on Oct. 18, 2023.
Original Filing: 301504584.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA) Office of Natl Drug Control Policy (NDCP)
Lobbying Issues
Funding for Substance Use Prevention Treatment and Recovery Services block grant
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Implementation of legislative provisions related to substance abuse treatment and prevention; IMD exclusion; Family First Prevention Services Act provisions; 42 CFR part 2 patient confidentiality reform; Family First Transition Act, workforce development
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
2nd Quarter, 2023
In Q2, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America , earning $10,000. The report was filed on July 19, 2023.
Original Filing: 301481870.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA) Office of Natl Drug Control Policy (NDCP)
Lobbying Issues
Funding for Substance Abuse Prevention and Treatment block grant
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Implementation of legislative provisions related to substance abuse treatment and prevention; IMD exclusion; Family First Prevention Services Act provisions; 42 CFR part 2 patient confidentiality reform; Family First Transition Act, workforce development
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
1st Quarter, 2023
In Q1, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America , earning $10,000. The report was filed on April 19, 2023.
Original Filing: 301457664.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA) Office of Natl Drug Control Policy (NDCP)
Lobbying Issues
Funding for Substance Abuse Prevention and Treatment block grant
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Implementation of legislative provisions related to substance abuse treatment and prevention; IMD exclusion; Family First Prevention Services Act provisions; 42 CFR part 2 patient confidentiality reform; Family First Transition Act, workforce development
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
4th Quarter, 2022
In Q4, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America , earning $10,000. The report was filed on Jan. 20, 2023.
Original Filing: 301440291.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA) Office of Natl Drug Control Policy (NDCP)
Lobbying Issues
Funding for Substance Abuse Prevention and Treatment block grant
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Implementation of legislative provisions related to substance abuse treatment and prevention; H.R. 6 - SUPPORT Act implementation, including IMD exclusion provisions (including the MIND Act), and Family First Prevention Services Act provisions; 42 CFR part 2 patient confidentiality reform; Family First Transition Act, workforce development
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
3rd Quarter, 2022
In Q3, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America , earning $10,000. The report was filed on Oct. 19, 2022.
Original Filing: 301411109.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA) Office of Natl Drug Control Policy (NDCP)
Lobbying Issues
Funding for Substance Abuse Prevention and Treatment block grant
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Implementation of legislative provisions related to substance abuse treatment and prevention; H.R. 6 - SUPPORT Act implementation, including IMD exclusion provisions (including HR 6926, the MIND Act), and Family First Prevention Services Act provisions; 42 CFR part 2 patient confidentiality reform; Family First Transition Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
2nd Quarter, 2022
In Q2, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America , earning $10,000. The report was filed on July 20, 2022.
Original Filing: 301391824.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Funding for Substance Abuse Prevention and Treatment block grant
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Implementation of legislative provisions related to substance abuse treatment and prevention; H.R. 6 - SUPPORT Act implementation, including IMD exclusion provisions (including HR 6926, the MIND Act), and Family First Prevention Services Act provisions; 42 CFR part 2 patient confidentiality reform; Family First Transition Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
1st Quarter, 2022
In Q1, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America , earning $10,000. The report was filed on April 20, 2022.
Original Filing: 301369608.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Funding for Substance Abuse Prevention and Treatment block grant; CARES Act Implementation and support for SUD treatment programs affected by the COVID-19 epidemic; CRRSSA/ARP Act Implementation
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Implementation of legislative provisions related to substance abuse treatment and prevention; H.R. 6 - SUPPORT Act implementation, including IMD exclusion provisions (including HR 6926, the MIND Act), and Family First Prevention Services Act provisions; 42 CFR part 2 patient confidentiality reform; Family First Transition Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
4th Quarter, 2021
In Q4, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America , earning $10,000. The report was filed on Jan. 20, 2022.
Original Filing: 301337959.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Funding for Substance Abuse Prevention and Treatment block grant; CARES Act Implementation and support for SUD treatment programs affected by the COVID-19 epidemic; CRRSSA/ARP Act Implementation
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Implementation of legislative provisions related to substance abuse treatment and prevention; H.R. 6 - SUPPORT Act implementation, including IMD exclusion provisions (including HR 6926, the MIND Act), and Family First Prevention Services Act provisions; 42 CFR part 2 patient confidentiality reform; Family First Transition Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
3rd Quarter, 2021
In Q3, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America , earning $10,000. The report was filed on Oct. 19, 2021.
Original Filing: 301305650.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Funding for Substance Abuse Prevention and Treatment block grant; CARES Act Implementation and support for SUD treatment programs affected by the COVID-19 epidemic; CRRSSA/ARP Act Implementation
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Implementation of legislative provisions related to substance abuse treatment and prevention; H.R. 6 - SUPPORT Act implementation, including IMD exclusion provisions (including HR 6926, the MIND Act), and Family First Prevention Services Act provisions; 42 CFR part 2 patient confidentiality reform; Family First Transition Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
2nd Quarter, 2021
In Q2, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America , earning $10,000. The report was filed on July 20, 2021.
Original Filing: 301284656.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Funding for Substance Abuse Prevention and Treatment block grant; CARES Act Implementation and support for SUD treatment programs affected by the COVID-19 epidemic; CRRSSA/ARP Act Implementation
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Implementation of legislative provisions related to substance abuse treatment and prevention; H.R. 6 - SUPPORT Act implementation, including IMD exclusion provisions (including HR 6926, the MIND Act), and Family First Prevention Services Act provisions; 42 CFR part 2 patient confidentiality reform; Family First Transition Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
1st Quarter, 2021
In Q1, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America , earning $10,000. The report was filed on April 19, 2021.
Original Filing: 301258618.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Funding for Substance Abuse Prevention and Treatment block grant; CARES Act Implementation and support for SUD treatment programs affected by the COVID-19 epidemic; HEALS/HEROES Ac
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Implementation of legislative provisions related to substance abuse treatment and prevention; H.R. 6 - SUPPORT Act implementation, including IMD exclusion provisions (including HR 6926, the MIND Act), and Family First Prevention Services Act provisions; 42 CFR part 2 patient confidentiality reform; Family First Transition Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
4th Quarter, 2020
In Q4, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America , earning $10,000. The report was filed on Jan. 19, 2021.
Original Filing: 301234724.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Funding for Substance Abuse Prevention and Treatment block grant; CARES Act Implementation and support for SUD treatment programs affected by the COVID-19 epidemic; HEALS/HEROES Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Implementation of legislative provisions related to substance abuse treatment and prevention; H.R. 6 - SUPPORT Act implementation, including IMD exclusion provisions (including HR 6926, the MIND Act), and Family First Prevention Services Act provisions; 42 CFR part 2 patient confidentiality reform; Family First Transition Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
3rd Quarter, 2020
In Q3, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America , earning $10,000. The report was filed on Oct. 15, 2020.
Original Filing: 301210387.xml
Lobbying Issues
Implementation of healthcare reform as it relates to access to substance abuse treatment and prevention and mental health services and parity.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Funding for Substance Abuse Prevention and Treatment block grant; CARES Act Implementation and support for SUD treatment programs affected by the COVID-19 epidemic
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Implementation of legislative provisions related to substance abuse treatment and prevention; H.R. 6 - SUPPORT Act implementation, including IMD exclusion provisions (including HR 6926, the MIND Act), and Family First Prevention Services Act provisions; 42 CFR part 2 patient confidentiality reform; Family First Transition Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
2nd Quarter, 2020
In Q2, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America , earning $10,000. The report was filed on July 15, 2020.
Original Filing: 301188248.xml
Lobbying Issues
Implementation of healthcare reform as it relates to access to substance abuse treatment and prevention and mental health services and parity.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Funding for Substance Abuse Prevention and Treatment block grant; CARES Act Implementation and support for SUD treatment programs affected by the COVID-19 epidemic
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Implementation of legislative provisions related to substance abuse treatment and prevention; HR 6- Support ACT Implementation including IMD exclusion provisions and Family First Prevention Services Act and Family First Transition Act provisions; 42 CFR part 2 patient confidentiality reform
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
1st Quarter, 2020
In Q1, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America , earning $10,000. The report was filed on April 17, 2020.
Original Filing: 301169625.xml
Lobbying Issues
Implementation of healthcare reform as it relates to access to substance abuse treatment and prevention and mental health services and parity.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Funding for Substance Abuse Prevention and Treatment block grant; CARES Act Implementation and support for SUD treatment programs affected by the COVID-19 epidemic
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Implementation of legislative provisions related to substance abuse treatment and prevention; HR 6- Support ACT Implementation including IMD exclusion provisions and Family First Prevention Services Act and Family First Transition Act provisions; 42 CFR part 2 patient confidentiality reform
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
4th Quarter, 2019
In Q4, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America , earning $10,000. The report was filed on Jan. 17, 2020.
Original Filing: 301108740.xml
Lobbying Issues
Implementation of healthcare reform as it relates to access to substance abuse treatment and prevention and mental health services and parity.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Funding for Substance Abuse Prevention and Treatment block grant
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Implementation of legislative provisions related to substance abuse treatment and prevention; HR 6- Support ACT Implementation including IMD exclusion provisions and Family First Prevention Services Act and Family First Transition Act provisions; 42 CFR part 2 patient confidentiality reform
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
3rd Quarter, 2019
In Q3, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America , earning $10,000. The report was filed on Oct. 15, 2019.
Original Filing: 301065647.xml
Lobbying Issues
Implementation of healthcare reform as it relates to access to substance abuse treatment and prevention and mental health services and parity.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Funding for Substance Abuse Prevention and Treatment block grant
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Implementation of legislative provisions related to substance abuse treatment and prevention; HR 6- Support ACT Implementation including IMD exclusion provisions and Family First Prevention Services Act provisions; 42 CFR part 2 patient confidentiality reform
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
2nd Quarter, 2019
In Q2, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America , earning $10,000. The report was filed on July 19, 2019.
Original Filing: 301050493.xml
Lobbying Issues
Implementation of healthcare reform as it relates to access to substance abuse treatment and prevention and mental health services and parity.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Funding for Substance Abuse Prevention and Treatment block grant
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Implementation of legislative provisions related to substance abuse treatment and prevention; HR 6- Support ACT Implementation including IMD exclusion provisions and Family First Prevention Services Act provisions; 42 CFR part 2 patient confidentiality reform
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
1st Quarter, 2019
In Q1, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America , earning $10,000. The report was filed on April 16, 2019.
Original Filing: 301026350.xml
Lobbying Issues
Implementation of healthcare reform as it relates to access to substance abuse treatment and prevention and mental health services and parity.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Funding for Substance Abuse Prevention and Treatment block grant
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Implementation of legislative provisions related to substance abuse treatment and prevention; HR 6- Support ACT Implementation including IMD exclusion provisions and Family First Prevention Services Act provisions
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
4th Quarter, 2018
In Q4, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America , earning $10,000. The report was filed on Jan. 17, 2019.
Original Filing: 301006323.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity;
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Funding for Substance Abuse Prevention and Treatment block grant
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
HCR: HCR: Implementation of health care reform law as it relates to substance abuse treatment and prevention, Medicaid - IMD exclusion; parity for SUD treatment; S. 524, access to treatment under Medicaid and Essential health benefits the Comprehensive Addiction & Recovery Act, specifically provisions that relate to SUD Treatment. S.1169 Medcaid Coverage for Addiction Recovery Expansion (Medicaid CARE) act , H.R. 2938 Road to Recovery Act, H.R. 2687 Medicaid Coverage for Addiction Recovery Expansion (Medicaid CARE) Act; monitoring policies and regulations related to the Presidents declaration of the opioid crisis as a public health emergency under the Public Health Service Act; H.R. 5797 Legislation to reform IMD exclusion; Provisions related to IMD exclusion in HR 6 and enacted into law as the SUPPORT for Patients and Communities Act, designated Public Law 115-271. Patient privacy provisions in H.R. 6082, the Overdose Prevention and Patient Safety Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
3rd Quarter, 2018
In Q3, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America , earning $10,000. The report was filed on Oct. 19, 2018.
Original Filing: 300992145.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity;
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Funding for Substance Abuse Prevention and Treatment block grant
Agencies Lobbied
U.S. Senate U.S. House of Representatives Substance Abuse & Mental Health Services Administration (SAMHSA)
2nd Quarter, 2018
In Q2, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America , earning $10,000. The report was filed on July 20, 2018.
Original Filing: 300975936.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity;
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Implementation of health care reform law as it relates to substance abuse treatment and prevention, Medicaid - IMD exclusion; parity for SUD treatment;S. 524, ccess to treatment under Medicaid and Essential health benefits the Comprehensive Addiction & Recovery Act, specifically provisions that relate to SUD Treatment. S.1169 Medcaid Coverage for Addiction Recovery Expansion (Medicaid CARE) act , H.R. 2938 Road to Recovery Act, H.R. 2687 Medicaid Coverage for Addiction Recovery Expansion (Medicaid CARE) Act; monitoring policies and regulations related to the Presidents declaration of the opioid crisis as a public health emergency under the Public Health Service Act; H.R. 5797 Legislation to reform IMD exclusion
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Funding for Substance Abuse Prevention and Treatment block grant
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Substance Abuse & Mental Health Services Administration (SAMHSA)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Substance Abuse & Mental Health Services Administration (SAMHSA)
1st Quarter, 2018
In Q1, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America , earning $10,000. The report was filed on April 18, 2018.
Original Filing: 300947390.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity;
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Natl Drug Control Policy (NDCP) Centers For Medicare and Medicaid Services (CMS) Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity; Implementation of Sec. 2707 of health care reform legislation; FY18 and FY19 appropriations related to provision of mental health and substance abuse treatment services, Medicaid implementation of IMD Exclusion; HR 1892 provisions related to the Family First Prevention Services Act and SUD Treatment; S. 1949 and HR 2646 provisions that relate to IMD exclusion and SUD treatment; implementation of S. 524 provisions related to SUD treatment and funding for the emergency response to the opioid epidemic; S. 1169 Medicaid Coverage for Addiction Recovery Expansion (Medicaid CARE) Act, H.R.2938 Road to Recovery Act, H.R. 2687 Medicaid Coverage for Addiction Recovery Expansion (Medicaid CARE Act), monitoring policies and regulations related to the President's declaration of the opioid crisis as a public health emergency under the Public Health Service Act; Medicaid coverage of SUD treatment and essential health benefits
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Natl Drug Control Policy (NDCP) Centers For Medicare and Medicaid Services (CMS) Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Funding for social services block grants
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Natl Drug Control Policy (NDCP) Centers For Medicare and Medicaid Services (CMS) Substance Abuse & Mental Health Services Administration (SAMHSA)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Natl Drug Control Policy (NDCP) Centers For Medicare and Medicaid Services (CMS) Substance Abuse & Mental Health Services Administration (SAMHSA)
4th Quarter, 2017
In Q4, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America , earning $10,000. The report was filed on Jan. 18, 2018.
Original Filing: 300926376.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity;
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Natl Drug Control Policy (NDCP)
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity; Implementation of Sec. 2707 of health care reform legislation; FY18 appropriations related to provision of mental health and substance abuse treatment services, Medicaid implementation of IMD Exclusion; H.R. 2664- Title V as it related to Medicaid and the IMD exclusion; S.1945 title V as it relates to Medicaid and IMD exclusion; S. 1949 and HR 2646 provisions that relate to IMD exclusion and SUD treatment; implementation of S. 524 provisions related to SUD treatment and funding for the emergency response to the opioid epidemic; S. 1169 Medicaid Coverage for Addiction Recovery Expansion (Medicaid CARE) Act, H.R.2938 Road to Recovery Act, H.R. 2687 Medicaid Coverage for Addiction Recovery Expansion (Medicaid CARE Act), monitoring policies and regulations related to the President's declaration of the opioid crisis as a public health emergency under the Public Health Service Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Natl Drug Control Policy (NDCP)
Lobbying Issues
Funding for social services block grants
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Natl Drug Control Policy (NDCP)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Natl Drug Control Policy (NDCP)
3rd Quarter, 2017
In Q3, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America , earning $10,000. The report was filed on Oct. 17, 2017.
Original Filing: 300905236.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity;
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Office of Natl Drug Control Policy (NDCP) Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity; Implementation of Sec. 2707 of health care reform legislation; FY18 appropriations related to provision of mental health and substance abuse treatment services, Medicaid implementation of IMD Exclusion; H.R. 2664- Title V as it related to Medicaid and the IMD exclusion; S.1945 title V as it relates to Medicaid and IMD exclusion; S. 1949 and HR 2646 provisions that relate to IMD exclusion and SUD treatment; implementation of S. 524 provisions related to SUD treatment and funding for the emergency response to the opioid epidemic; Graham Cassidy Substitute Amendment provisions related to SUD treatment, Medicaid coverage of SUD treatment, and essential health benefits, S. 1169 Medicaid Coverage for Addiction Recovery Expansion (Medicaid CARE) Act, H.R.2938 Road to Recovery Act, H.R. 2687 Medicaid Coverage for Addiction Recovery Expansion (Medicaid CARE Act)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Office of Natl Drug Control Policy (NDCP) Substance Abuse & Mental Health Services Administration (SAMHSA)
Type of Issue
Health Issues Budget/Appropriations Medicare/Medicaid
2nd Quarter, 2017
In Q2, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America , earning $10,000. The report was filed on July 18, 2017.
Original Filing: 300887705.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity; Implementation of Sec. 2707 of health care reform legislation; FY17 and FY18 appropriations related to provision of mental health and substance abuse treatment services, Medicaid implementation of IMD Exclusion;implementation of S. 524 provisions related to SUD treatment and funding for the emergency response to the opioid epidemic; HR 1628, AHCA provisions related to SUD treatment, Medicaid coverage of SUD treatment, and essential health benefits
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Office of Natl Drug Control Policy (NDCP) Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity; Implementation of Sec. 2707 of health care reform legislation; FY17 and FY18 appropriations related to provision of mental health and substance abuse treatment services, Medicaid implementation of IMD Exclusion; H.R. 2664- Title V as it related to Medicaid and the IMD exclusion; S.1945 title V as it relates to Medicaid and IMD exclusion; S. 1949 and HR 2646 provisions that relate to IMD exclusion and SUD treatment; implementation of S. 524 provisions related to SUD treatment and funding for the emergency response to the opioid epidemic; HR 1628, AHCA provisions related to SUD treatment, Medicaid coverage of SUD treatment, and essential health benefits, S. 1169 Medicaid Coverage for Addiction Recovery Expansion (Medicaid CARE) Act, H.R.2938 Road to Recovery Act, H.R. 2687 Medicaid Coverage for Addiction Recovery Expansion (Medicaid CARE Act)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Office of Natl Drug Control Policy (NDCP) Substance Abuse & Mental Health Services Administration (SAMHSA)
Type of Issue
Health Issues Budget/Appropriations Medicare/Medicaid
1st Quarter, 2017
In Q1, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America , earning $10,000. The report was filed on April 21, 2017.
Original Filing: 300878675.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity; Implementation of Sec. 2707 of health care reform legislation; FY17 and FY18 appropriations related to provision of mental health and substance abuse treatment services, Medicaid implementation of IMD Exclusion;implementation of S. 524 provisions related to SUD treatment and funding for the emergency response to the opioid epidemic; HR 1628, AHCA provisions related to SUD treatment, Medicaid coverage of SUD treatment, and essential health benefits
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Office of Natl Drug Control Policy (NDCP) Substance Abuse & Mental Health Services Administration (SAMHSA)
Type of Issue
Alcohol & Drug Abuse Health Issues Budget/Appropriations Medicare/Medicaid
4th Quarter, 2016
In Q4, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America , earning $10,000. The report was filed on Jan. 20, 2017.
Original Filing: 300852226.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity; Implementation of Sec. 2707 of health care reform legislation; FY17 appropriations related to provision of mental health and substance abuse treatment services; Medicaid implementation of IMD Exclusion; HR 2664 - Title V as it relates to Medicaid and the IMD exclusion and S. 1945 - Title V as it relates to Medicaid and the IMD Exclusion; S. 1949 and H.R. 2646 provisions that relate to the IMD exclusion and such treatment; implementation of S. 524 provisions related to SUD treatment and funding for the emergency response to the opioid epidemic
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Office of Natl Drug Control Policy (NDCP) Substance Abuse & Mental Health Services Administration (SAMHSA)
Type of Issue
Alcohol & Drug Abuse Health Issues Budget/Appropriations Medicare/Medicaid
3rd Quarter, 2016
In Q3, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America , earning $10,000. The report was filed on Oct. 20, 2016.
Original Filing: 300839762.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity; Implementation of Sec. 2707 of health care reform legislation; FY17 appropriations related to provision of mental health and substance abuse treatment services; Medicaid implementation of IMD Exclusion; HR 2664 - Title V as it relates to Medicaid and the IMD exclusion and S. 1945 - Title V as it relates to Medicaid and the IMD Exclusion; S. 1949 and H.R. 2646 provisions that relate to the IMD exclusion and such treatment
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Office of Natl Drug Control Policy (NDCP) Substance Abuse & Mental Health Services Administration (SAMHSA)
Type of Issue
Alcohol & Drug Abuse Health Issues Budget/Appropriations Medicare/Medicaid
2nd Quarter, 2016
In Q2, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America , earning $10,000. The report was filed on July 15, 2016.
Original Filing: 300810810.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity; Implementation of Sec. 2707 of health care reform legislation; FY17 appropriations related to provision of mental health and substance abuse treatment services; Medicaid implementation of IMD Exclusion; HR 2664 - Title V as it relates to Medicaid and the IMD exclusion and S. 1945 - Title V as it relates to Medicaid and the IMD Exclusion; S. 1949 and H.R. 2646 provisions that relate to the IMD exclusion and such treatment
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Office of Natl Drug Control Policy (NDCP) Substance Abuse & Mental Health Services Administration (SAMHSA)
Type of Issue
Alcohol & Drug Abuse Health Issues Budget/Appropriations Medicare/Medicaid
1st Quarter, 2016
In Q1, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America , earning $10,000. The report was filed on April 19, 2016.
Original Filing: 300797158.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity; Implementation of Sec. 2707 of health care reform legislation; FY17 appropriations related to provision of mental health and substance abuse treatment services; Medicaid implementation of IMD Exclusion; HR 2664 - Title V as it relates to Medicaid and the IMD exclusion and S. 1945 - Title V as it relates to Medicaid and the IMD Exclusion
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Office of Natl Drug Control Policy (NDCP)
Type of Issue
Alcohol & Drug Abuse Health Issues Budget/Appropriations Medicare/Medicaid
4th Quarter, 2015
In Q4, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America (formerly Therapeutic Communities of America) , earning $10,000. The report was filed on Jan. 20, 2016.
Original Filing: 300784279.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity; Implementation of Sec. 2707 of health care reform legislation; FY16 appropriations related to provision of mental health and substance abuse treatment services; Medicaid implementation of IMD Exclusion; HR 2664 - Title V as it relates to Medicaid and the IMD exclusion and S. 1945 - Title V as it relates to Medicaid and the IMD Exclusion
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Alcohol & Drug Abuse Health Issues Budget/Appropriations Medicare/Medicaid
3rd Quarter, 2015
In Q3, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America (formerly Therapeutic Communities of America) , earning $10,000. The report was filed on Oct. 20, 2015.
Original Filing: 300764186.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity; Implementation of Sec. 2707 of health care reform legislation; FY16 appropriations related to provision of mental health and substance abuse treatment services; Medicaid implementation of IMD Exclusion; HR 2664 - Title V as it relates to Medicaid and the IMD exclusion and S. 1945 - Title V as it relates to Medicaid and the IMD Exclusion
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Alcohol & Drug Abuse Health Issues Budget/Appropriations Medicare/Medicaid
2nd Quarter, 2015
In Q2, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America (formerly Therapeutic Communities of America) , earning $10,000. The report was filed on July 20, 2015.
Original Filing: 300742958.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity; Implementation of Sec. 2707 of health care reform legislation; FY16 appropriations related to provision of mental health and substance abuse treatment services; Medicaid implementation of IMD Exclusion
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Alcohol & Drug Abuse Health Issues Budget/Appropriations Medicare/Medicaid
1st Quarter, 2015
In Q1, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America (formerly Therapeutic Communities of America) , earning $10,000. The report was filed on April 19, 2015.
Original Filing: 300721289.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity; Implementation of Sec. 2707 of health care reform legislation; FY16 appropriations related to provision of mental health and substance abuse treatment services; Medicaid implementation of IMD Exclusion
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Alcohol & Drug Abuse Health Issues Budget/Appropriations Medicare/Medicaid
4th Quarter, 2014
In Q4, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America (formerly Therapeutic Communities of America) , earning $10,000. The report was filed on Jan. 20, 2015.
Original Filing: 300704378.xml
Lobbying Issues
Implementation of healthcare reform as it relates to access to substance abuse treatment and prevention and mental health services and parity
Implementation of Sec.2707 of healthcare reform legislation
FY14 and FY15 appropriations related to the provision of mental health and substance abuse treatment services and the implementation of sequestration
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Alcohol & Drug Abuse Health Issues Budget/Appropriations Medicare/Medicaid
3rd Quarter, 2014
In Q3, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America (formerly Therapeutic Communities of America) , earning $10,000. The report was filed on Oct. 20, 2014.
Original Filing: 300687378.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity; Implementation of Sec. 2707 of health care reform legislation; FY14 and FY15 appropriations related to provision of mental health and substance abuse treatment services
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity; Implementation of Sec. 2707 of health care reform legislation; FY15 appropriations related to provision of mental health and substance abuse treatment services
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Medicare/Medicaid Budget/Appropriations
2nd Quarter, 2014
In Q2, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America (formerly Therapeutic Communities of America) , earning $10,000. The report was filed on July 21, 2014.
Original Filing: 300667778.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity; Implementation of Sec. 2707 of health care reform legislation; FY14 and FY15 appropriations related to provision of mental health and substance abuse treatment services
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity; Implementation of Sec. 2707 of health care reform legislation; FY15 appropriations related to provision of mental health and substance abuse treatment services
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Medicare/Medicaid Budget/Appropriations
1st Quarter, 2014
In Q1, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America (formerly Therapeutic Communities of America) , earning $10,000. The report was filed on April 21, 2014.
Original Filing: 300648566.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity; Implementation of Sec. 2707 of health care reform legislation; FY14 and FY15 appropriations related to provision of mental health and substance abuse treatment services
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Alcohol & Drug Abuse Health Issues Medicare/Medicaid
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity; Implementation of Sec. 2707 of health care reform legislation; FY15 appropriations related to provision of mental health and substance abuse treatment services
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
4th Quarter, 2013
In Q4, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America (formerly Therapeutic Communities of America) , earning $10,000. The report was filed on Jan. 21, 2014.
Original Filing: 300624050.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity; Implementation of Sec. 2707 of health care reform legislation; FY14 appropriations related to provision of mental health and substance abuse treatment services
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Alcohol & Drug Abuse Health Issues Medicare/Medicaid Budget/Appropriations
3rd Quarter, 2013
In Q3, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America (formerly Therapeutic Communities of America) , earning $10,000. The report was filed on Oct. 18, 2013.
Original Filing: 300597751.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity; Implementation of Sec. 2707 of health care reform legislation; FY14 appropriations related to provision of mental health and substance abuse treatment services
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Alcohol & Drug Abuse Health Issues Medicare/Medicaid Budget/Appropriations
2nd Quarter, 2013
In Q2, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America (formerly Therapeutic Communities of America) , earning $10,000. The report was filed on July 22, 2013.
Original Filing: 300585453.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity; Implementation of Sec. 2707 of health care reform legislation; FY14 appropriations related to provision of mental health and substance abuse treatment services
Implementation of Sequestration
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Alcohol & Drug Abuse Health Issues Medicare/Medicaid Budget/Appropriations
1st Quarter, 2013
In Q1, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America (formerly Therapeutic Communities of America) , earning $10,000. The report was filed on April 22, 2013.
Original Filing: 300560943.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services and parity; Implementation of Sec. 2707 of health care reform legislation; FY14 appropriations related to provision of mental health and substance abuse treatment services
Implementation of Sequestration
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Alcohol & Drug Abuse Health Issues Medicare/Medicaid Budget/Appropriations
4th Quarter, 2012
In Q4, WINNING STRATEGIES WASHINGTON lobbied for Treatment Communities of America (formerly Therapeutic Communities of America) , earning $10,000. The report was filed on Jan. 22, 2013.
Original Filing: 300539877.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services; Implementation of Sec. 2707 of health care reform legislation; FY13 appropriations related to provision of mental health and substance abuse treatment services
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Alcohol & Drug Abuse Health Issues Medicare/Medicaid Budget/Appropriations
3rd Quarter, 2012
In Q3, WINNING STRATEGIES WASHINGTON lobbied for Therapeutic Communities of America , earning $10,000. The report was filed on Oct. 22, 2012.
Original Filing: 300518757.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services; Implementation of Sec. 2707 of health care reform legislation; FY13 appropriations related to provision of mental health and substance abuse treatment services
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Alcohol & Drug Abuse Health Issues Medicare/Medicaid Budget/Appropriations
2nd Quarter, 2012
In Q2, WINNING STRATEGIES WASHINGTON lobbied for Therapeutic Communities of America , earning $10,000. The report was filed on July 20, 2012.
Original Filing: 300495980.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services; Implementation of Sec. 2707 of health care reform legislation; FY13 appropriations related to provision of mental health and substance abuse treatment services
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Alcohol & Drug Abuse Health Issues Medicare/Medicaid Budget/Appropriations
1st Quarter, 2012
In Q1, WINNING STRATEGIES WASHINGTON lobbied for Therapeutic Communities of America , earning $10,000. The report was filed on April 19, 2012.
Original Filing: 300467353.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services; Implementation of Sec. 2707 of health care reform legislation; FY13 appropriations related to provision of mental health and substance abuse treatment services
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Alcohol & Drug Abuse Health Issues Medicare/Medicaid Budget/Appropriations
4th Quarter, 2011
In Q4, WINNING STRATEGIES WASHINGTON lobbied for Therapeutic Communities of America , earning $10,000. The report was filed on Jan. 20, 2012.
Original Filing: 300452387.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services; Implementation of Sec. 2707 of health care reform legislation; FY12 appropriations related to provision of mental health and substance abuse treatment services
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Alcohol & Drug Abuse Health Issues
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services; Implementation of Sec. 2707 of health care reform legislation; FY12 appropriations related to provision of mental health and substance abuse treatment servicesc
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services; Implementation of Sec. 2707 of health care reform legislation; FY12 appropriations related to provision of mental health and substance abuse treatment services
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
3rd Quarter, 2011
In Q3, WINNING STRATEGIES WASHINGTON lobbied for Therapeutic Communities of America , earning $10,000. The report was filed on Oct. 19, 2011.
Original Filing: 300421194.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services; Implementation of Sec. 2707 of health care reform legislation; FY12 appropriations related to provision of mental health and substance abuse treatment services
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Alcohol & Drug Abuse Health Issues
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services; Implementation of Sec. 2707 of health care reform legislation; FY12 appropriations related to provision of mental health and substance abuse treatment servicesc
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services; Implementation of Sec. 2707 of health care reform legislation; FY12 appropriations related to provision of mental health and substance abuse treatment services
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
2nd Quarter, 2011
In Q2, WINNING STRATEGIES WASHINGTON lobbied for Therapeutic Communities of America , earning $10,000. The report was filed on July 20, 2011.
Original Filing: 300403546.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services; Implementation of Sec. 2707 of health care reform legislation; FY11, FY12 appropriations related to provision of mental health and substance abuse treatment services
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Alcohol & Drug Abuse Health Issues Budget/Appropriations
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse treatment and prevention and mental health services; Implementation of Sec. 2707 of health care reform legislation; FY11, FY12 appropriations related to provision of mental health and substance abuse treatment servicesc
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
1st Quarter, 2011
In Q1, WINNING STRATEGIES WASHINGTON lobbied for Therapeutic Communities of America , earning $10,000. The report was filed on April 20, 2011.
Original Filing: 300374705.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse and mental health services; Implementation of Sec. 2707 of health care reform legislation; FY11, FY12 appropriations related to provision of mental health and substance abuse services
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Alcohol & Drug Abuse Health Issues Medicare/Medicaid Budget/Appropriations
4th Quarter, 2010
In Q4, WINNING STRATEGIES WASHINGTON lobbied for Therapeutic Communities of America , earning $10,000. The report was filed on Jan. 20, 2011.
Original Filing: 300353976.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse and mental health services; Implementation of Sec. 2707 of health care reform legislation; FY11 appropriations related to provision of mental health and substance abuse services
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Alcohol & Drug Abuse Health Issues Medicare/Medicaid
Lobbying Issues
FY11 appropriations related to provision of mental health and substance abuse services
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2010
In Q3, WINNING STRATEGIES WASHINGTON lobbied for Therapeutic Communities of America , earning $10,000. The report was filed on Oct. 20, 2010.
Original Filing: 300324049.xml
Lobbying Issues
Implementation of health care reform as it relates to access to substance abuse and mental health services; Implementation of Sec. 2707 of health care reform legislation; FY11 appropriations related to provision of mental health and substance abuse services
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Implementation of health care reform as it relates access to substance abuse and mental health services; Implementation of Sec. 2707 of health care reform legislation; FY11 appropriations related to provision of mental health and substance abuse services
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Health Issues Medicare/Medicaid
Lobbying Issues
FY11 appropriations related to provision of mental health and substance abuse services
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2010
In Q2, WINNING STRATEGIES WASHINGTON lobbied for Therapeutic Communities of America . The report was filed on July 20, 2010.
Original Filing: 300299825.xml
Lobbying Issues
Implementation of health care reform as it relates access to substance abuse and mental health services; Implementation of Sec. 2707 of health care reform legislation; FY11 appropriations related to provision of mental health and substance abuse services
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Alcohol & Drug Abuse Health Issues Medicare/Medicaid Budget/Appropriations
2nd Quarter, 2010
WINNING STRATEGIES WASHINGTON filed a lobbying registration on June 28, 2010 to represent Therapeutic Communities of America, effective June 8, 2010.
Original Filing: 300281497.xml
Issue(s) they said they’d lobby about: Implementation of health care reform as it relates access to substance abuse and mental health services; Implementation of Sec. 2707 of health care reform legislation; FY11 appropriations related to provision of mental health and substance abuse services .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate